IL222757A0 - Electrokinetic fluid and uses thereof for protection against neurotoxic agents - Google Patents
Electrokinetic fluid and uses thereof for protection against neurotoxic agentsInfo
- Publication number
- IL222757A0 IL222757A0 IL222757A IL22275712A IL222757A0 IL 222757 A0 IL222757 A0 IL 222757A0 IL 222757 A IL222757 A IL 222757A IL 22275712 A IL22275712 A IL 22275712A IL 222757 A0 IL222757 A0 IL 222757A0
- Authority
- IL
- Israel
- Prior art keywords
- protection against
- neurotoxic agents
- electrokinetic fluid
- against neurotoxic
- electrokinetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/771,476 US20100310609A1 (en) | 2007-10-25 | 2010-04-30 | Compositions and methods for treatment of neurodegenerative diseases |
US41389910P | 2010-11-15 | 2010-11-15 | |
US201161454409P | 2011-03-18 | 2011-03-18 | |
PCT/US2011/034508 WO2011137317A1 (en) | 2010-04-30 | 2011-04-29 | Methods and compositions for protecting against neurotoxic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
IL222757A0 true IL222757A0 (en) | 2012-12-31 |
Family
ID=44861925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL222757A IL222757A0 (en) | 2010-04-30 | 2012-10-29 | Electrokinetic fluid and uses thereof for protection against neurotoxic agents |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2563121A4 (ko) |
JP (1) | JP5941908B2 (ko) |
KR (1) | KR20130113314A (ko) |
CN (1) | CN103002734A (ko) |
AU (1) | AU2011245223B2 (ko) |
BR (1) | BR112012027905A2 (ko) |
CA (1) | CA2798127A1 (ko) |
EA (1) | EA201201483A1 (ko) |
IL (1) | IL222757A0 (ko) |
MX (1) | MX2012012634A (ko) |
WO (1) | WO2011137317A1 (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9523090B2 (en) | 2007-10-25 | 2016-12-20 | Revalesio Corporation | Compositions and methods for treating inflammation |
US10125359B2 (en) | 2007-10-25 | 2018-11-13 | Revalesio Corporation | Compositions and methods for treating inflammation |
US9745567B2 (en) | 2008-04-28 | 2017-08-29 | Revalesio Corporation | Compositions and methods for treating multiple sclerosis |
CA2808189A1 (en) * | 2010-08-12 | 2012-02-16 | Revalesio Corporation | Compositions and methods for treatment of taupathy |
JP6159584B2 (ja) * | 2012-06-14 | 2017-07-05 | 松本 高明 | 輸液、輸液の製造方法および輸液装置 |
US9763992B2 (en) | 2014-02-13 | 2017-09-19 | Father Flanagan's Boys' Home | Treatment of noise induced hearing loss |
US20180243247A1 (en) * | 2017-02-28 | 2018-08-30 | Bryan J. Katz | Drug combinations for cerebrovascular disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05010042A (es) * | 2003-03-20 | 2006-05-25 | Aquaphotonics Inc | Composiciones de farmacos en micro-agregados, composiciones bioafectadoras, composiciones para el tratamiento corporal, medios de cultivo, alimentos y bebidas. |
ITMI20061737A1 (it) * | 2006-09-12 | 2008-03-13 | Snam Progetti | Procedimento per il trasporto di zolfo a basso rischio e ad emissione zero da depositi di zolfo solido in blocchi di notevoli dimensioni |
US20100310609A1 (en) * | 2007-10-25 | 2010-12-09 | Revalesio Corporation | Compositions and methods for treatment of neurodegenerative diseases |
US9745567B2 (en) * | 2008-04-28 | 2017-08-29 | Revalesio Corporation | Compositions and methods for treating multiple sclerosis |
CA2722658C (en) * | 2008-04-28 | 2018-09-18 | Richard L. Watson | Compositions and methods for treating multiple sclerosis |
-
2011
- 2011-04-29 CN CN2011800318038A patent/CN103002734A/zh active Pending
- 2011-04-29 EA EA201201483A patent/EA201201483A1/ru unknown
- 2011-04-29 JP JP2013508277A patent/JP5941908B2/ja not_active Expired - Fee Related
- 2011-04-29 AU AU2011245223A patent/AU2011245223B2/en not_active Ceased
- 2011-04-29 KR KR1020127031216A patent/KR20130113314A/ko not_active Application Discontinuation
- 2011-04-29 BR BR112012027905A patent/BR112012027905A2/pt not_active IP Right Cessation
- 2011-04-29 WO PCT/US2011/034508 patent/WO2011137317A1/en active Application Filing
- 2011-04-29 CA CA2798127A patent/CA2798127A1/en not_active Abandoned
- 2011-04-29 EP EP11775615.5A patent/EP2563121A4/en not_active Withdrawn
- 2011-04-29 MX MX2012012634A patent/MX2012012634A/es not_active Application Discontinuation
-
2012
- 2012-10-29 IL IL222757A patent/IL222757A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2013529195A (ja) | 2013-07-18 |
MX2012012634A (es) | 2013-02-26 |
BR112012027905A2 (pt) | 2015-09-08 |
AU2011245223A1 (en) | 2013-01-10 |
EA201201483A1 (ru) | 2013-04-30 |
EP2563121A4 (en) | 2016-05-11 |
CA2798127A1 (en) | 2011-11-03 |
CN103002734A (zh) | 2013-03-27 |
WO2011137317A1 (en) | 2011-11-03 |
JP5941908B2 (ja) | 2016-06-29 |
AU2011245223B2 (en) | 2015-11-19 |
EP2563121A1 (en) | 2013-03-06 |
KR20130113314A (ko) | 2013-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL239516A0 (en) | Tetrahazolinone compound and its use | |
IL237309A0 (en) | Benzocyclooctyne compounds and uses thereof | |
RS57375B1 (sr) | Heterociklični amini i njihove upotrebe | |
EP2927218A4 (en) | TETRAZOLINONE COMPOUND AND USE THEREOF | |
EP2588557A4 (en) | UNDERBREAKER AND DISPLACEMENT FLUID | |
EP2552953A4 (en) | FRIZZLED-BINDING SUBSTANCES AND ITS USES | |
HK1216683A1 (zh) | 用於整合的應用平台的系統和方法 | |
ZA201307236B (en) | Special fluid composition and use thereof | |
EP2922378A4 (en) | WORKING DEVICE AND COMPONENT MOUNTING DEVICE | |
LT2680873T (lt) | Priešgrybeliniai agentai ir jų panaudojimas | |
HK1211879A1 (en) | Materials and methods for protecting against neuromas | |
IL222757A0 (en) | Electrokinetic fluid and uses thereof for protection against neurotoxic agents | |
HK1171804A1 (en) | Work implementation without stopping flow | |
IL234756A0 (en) | A preparation for regulating the immune system and its uses | |
EP2886546A4 (en) | Heterocyclic compound and use thereof | |
EP2928875A4 (en) | FUNGICIDE COMPOUND AND USES THEREOF | |
ZA201208454B (en) | Use of diatomaceous earth in the pharmaceutocal industry | |
EP2872125A4 (en) | ANTIPROLIFERATIVE COMPOUNDS AND USES THEREOF | |
EP2813508A4 (en) | HETEROCYCLIC COMPOUND AND APPLICATION THEREOF | |
SG11201500317QA (en) | Elastomeric materials and use thereof | |
ZA201305427B (en) | Fluid displacement device | |
EP2605770A4 (en) | ANTIFUNGAL AGENTS AND USES THEREOF | |
GB2521056B (en) | Fluid displacement tool and method | |
FR2963983B1 (fr) | Composant de protection bidirectionnel dissymetrique | |
HK1210009A1 (en) | Compact fluid warmer |